Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.670
-0.040 (-2.34%)
At close: Aug 1, 2025, 4:00 PM
1.730
+0.060 (3.59%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Activision Blizzard Employees
Precigen had 143 employees as of December 31, 2024. The number of employees decreased by 59 or -29.21% compared to the previous year.
Employees
143
Change (1Y)
-59
Growth (1Y)
-29.21%
Revenue / Employee
$29,378
Profits / Employee
-$1,095,455
Market Cap
492.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143 | -59 | -29.21% |
| Dec 31, 2023 | 202 | -7 | -3.35% |
| Dec 31, 2022 | 209 | -302 | -59.10% |
| Dec 31, 2021 | 511 | 34 | 7.13% |
| Dec 31, 2020 | 477 | -380 | -44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PGEN News
- 25 days ago - Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha
- 2 months ago - Precigen Reports First Quarter 2025 Financial Results and Business Updates - PRNewsWire
- 3 months ago - Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th - PRNewsWire
- 4 months ago - Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Precigen Reports Full Year 2024 Financial Results and Business Updates - PRNewsWire
- 5 months ago - Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - PRNewsWire
- 5 months ago - Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement - Seeking Alpha
- 5 months ago - FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PRNewsWire